Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
Abstract Fermented butyrate exhibits an anti-inflammatory response to maintain immune homeostasis within the gut. However, the effect and underlying mechanism of butyrate on myasthenia gravis (MG) remain unclear. The changes in the gut microbiota and fecal contents of SCFAs in MG patients were exami...
Saved in:
| Main Authors: | Jing Sun, Juanjuan Chen, Qinfang Xie, Mengjiao Sun, Wenjing Zhang, Hongxia Wang, Ning Liu, Qi Wang, Manxia Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-11-01
|
| Series: | Journal of Inflammation |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12950-023-00363-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
by: Jing Sun, et al.
Published: (2024-11-01) -
Delayed diagnosis of distal myasthenia gravis: a case report
by: M. L. Cao, et al.
Published: (2024-11-01) -
The dilemma of thymectomy in myasthenia gravis
by: Pushpendra Nath Renjen, et al.
Published: (2020-01-01) -
Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment
by: Stefan Quasthoff
Published: (2024-11-01) -
Functioning of Patients with Myasthenia Gravis after Plasmapheresis
by: Monika Biercewicz
Published: (2020-06-01)